We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Clinicopathologic features of breast cancers that develop in women with previous benign breast disease.
- Authors
Visscher, Daniel W.; Frost, Marlene H.; Hartmann, Lynn C.; Frank, Ryan D.; Vierkant, Robert A.; McCullough, Ann E.; Winham, Stacey J.; Vachon, Celine M.; Ghosh, Karthik; Brandt, Kathleen R.; Farrell, Ann M.; Tarabishy, Yaman; Hieken, Tina J.; Haddad, Tufia C.; Kraft, Ruth A.; Radisky, Derek C.; Degnim, Amy C.
- Abstract
<bold>Background: </bold>Women with benign breast disease (BBD) have an increased risk of developing breast cancer (BC). Nearly 30% of all BCs develop in women with prior BBD. Information regarding features of the expected number of BCs after BBD would enhance individualized surveillance and prevention strategies for these women. In the current study, the authors sought to characterize BCs developing in a large cohort of women with BBD.<bold>Methods: </bold>The current study cohort included 13,485 women who underwent breast biopsy for mammographic or palpable concerns between 1967 and 2001. Biopsy slides were reviewed and classified as nonproliferative disease, proliferative disease without atypia, or atypical hyperplasia. BCs were identified by follow-up questionnaires, medical records, and Tumor Registry data. BC tissues were obtained and reviewed.<bold>Results: </bold>With median follow-up of 15.8 years, 1273 women developed BC. The majority of BCs were invasive (81%), of which 61% were ductal, 13% were mixed ductal/lobular, and 14% were lobular. Approximately two-thirds of the BC cases were intermediate or high grade, and 29% were lymph node positive. Cancer characteristics were similar across the 3 histologic categories of BBD, with a similar frequency of ductal carcinoma in situ, invasive disease, tumor size, time to invasive BC, histologic type of BC, lymph node positivity, and human epidermal growth factor receptor 2 positivity. Women with atypical hyperplasia were found to have a higher frequency of estrogen receptor-positive BC (91%) compared with women with proliferative disease without atypia (80%) or nonproliferative disease (85%) (P = .02).<bold>Conclusions: </bold>A substantial percentage of all BCs develop in women with prior BBD. The majority of BCs after BBD are invasive tumors of ductal type, with a substantial number demonstrating lymph node positivity. Of all the BCs in the current study, 84% were estrogen receptor positive. Prevention therapy should be strongly encouraged in higher-risk women with BBD.
- Subjects
BREAST cancer; CANCER prevention; CANCER in women; PUBLIC health surveillance; BREAST biopsy; TUMOR classification; HYPERPLASIA; METASTASIS; PROTEIN analysis; ADENOCARCINOMA; BIOPSY; BREAST; BREAST diseases; MAMMOGRAMS; BREAST tumors; CELL receptors; LONGITUDINAL method; LYMPH nodes; NEEDLE biopsy; PRECANCEROUS conditions; RESEARCH funding; RISK assessment; DUCTAL carcinoma; LOBULAR carcinoma; TUMOR grading; DIAGNOSIS
- Publication
Cancer (0008543X), 2016, Vol 122, Issue 3, p378
- ISSN
0008-543X
- Publication type
journal article
- DOI
10.1002/cncr.29766